sever
immunosuppress
hallmark
morbilliviru
infect
studi
underli
mechan
develop
ferret
model
canin
distemp
viru
infect
model
reproduc
clinic
sign
measl
lack
ferretspecif
reagent
limit
character
cellular
immun
respons
toward
clone
ferret
cytokin
establish
semiquantit
realtim
pcr
assay
demonstr
util
assay
compar
cytokin
profil
elicit
lethal
nonleth
strain
prodrom
phase
observ
gener
lack
cytokin
induct
anim
later
succumb
diseas
wherea
survivor
mount
robust
sustain
respons
newli
develop
cytokin
assay
strengthen
expand
ferret
model
morbilliviru
pathogenesi
studi
also
sever
human
respiratori
virus
includ
influenza
sar
morbillivirus
highli
contagi
respiratori
pathogen
caus
system
diseas
accompani
sever
immunosuppress
griffin
murphi
et
al
diseas
sever
vari
moder
sever
measl
mv
human
canin
distemp
viru
cdv
dog
usual
lethal
cdv
wild
carnivor
rinderpest
cattl
rima
duprex
regardless
ultim
diseas
outcom
infect
character
dramat
decreas
white
blood
cell
inhibit
lymphocyt
prolifer
within
first
week
infect
borrow
oldston
griffin
von
messl
et
al
howev
knowledg
regard
interact
host
immun
system
preced
these
event
remain
limit
sinc
mv
infect
human
certain
nonhuman
primat
establish
model
base
studi
close
relat
canin
distemp
viru
cdv
ferret
one
natur
host
von
messl
et
al
ferret
highli
sensit
diseas
part
succumb
infect
wild
type
viru
hand
infect
attenu
cdv
strain
result
diseas
sign
progress
parallel
mv
infect
human
kauffman
bergman
oconnor
viru
control
clearanc
surviv
anim
usual
occur
within
three
four
week
inocul
coincid
develop
neutral
antibodi
von
messl
milosev
cattaneo
von
messl
et
al
applic
model
studi
immun
respons
crucial
earli
phase
cdv
infect
far
difficult
specif
reagent
detect
cytokin
respons
ferret
readili
avail
lack
immunolog
reagent
constitut
major
limit
use
ferret
pathogenhost
interact
studi
becom
increasingli
attract
ferret
natur
suscept
sever
human
respiratori
pathogen
number
gastrointestin
bacteri
diseas
ball
long
recogn
model
efficaci
assess
new
vaccin
treatment
approach
influenza
recent
sever
acut
respiratori
syndrom
sar
also
use
studi
prion
diseas
bartz
et
al
maher
destefano
ter
meulen
et
al
purpos
present
studi
establish
mrnabas
cytokin
assay
ferret
valid
new
tool
compar
earli
host
respons
lethal
nonleth
cdv
infect
toward
complet
sequenc
ferret
cytokin
repres
differ
axe
cellular
immun
respons
develop
semiquantit
realtim
pcr
assay
evalu
cytokin
mrna
express
level
three
seven
day
inocul
found
surviv
associ
robust
sustain
respons
wherea
anim
succumb
diseas
experienc
gener
shutoff
cytokin
express
sinc
reagent
assess
cellular
immun
respons
ferret
commerci
avail
set
obtain
sequenc
ferret
cytokin
panel
includ
reflect
earli
innat
immun
respons
activ
tumor
necrosi
factor
tnf
interferon
ifn
interleukin
il
indic
polar
cytokin
mustelid
ferret
close
relat
carnivor
like
dog
cat
mckenna
bell
first
set
primer
therefor
base
canin
felin
sequenc
avail
genbank
initi
obtain
small
fragment
ferret
use
sequenc
measur
cytokin
mrna
induct
use
gelbas
assay
von
messl
svitek
cattaneo
develop
robust
versatil
realtim
pcrbase
assay
gener
repres
cytokin
profil
includ
pursu
sequenc
larger
part
open
read
frame
strategi
far
yield
complet
open
read
frame
consensu
sequenc
genbank
access
no
submit
partial
gene
sequenc
genbank
access
no
submit
compar
ferret
cytokin
respect
canin
felin
protein
observ
slightli
higher
overal
amino
acid
ident
ferret
dog
ferret
cat
tabl
degre
similar
amino
acid
nucleotid
level
data
shown
confirm
ident
obtain
sequenc
establish
valid
ferret
cytokin
realtim
pcr
assay
compar
sampl
anim
succumb
diseas
origin
survivor
differ
virus
includ
assur
identif
gener
characterist
diseas
outcom
rather
profil
associ
one
individu
strain
sampl
includ
lethal
group
origin
anim
infect
either
von
messl
milosev
cattaneo
rudd
cattaneo
von
messl
wherea
survivor
group
consist
individu
inocul
highli
pathogen
nonleth
strain
von
messl
milosev
cattaneo
survivor
chimer
virus
virus
envelop
glycoprotein
exchang
two
lethal
strain
caus
sever
diseas
mortal
unpublish
result
case
carri
egfpcontain
addit
transcript
unit
upstream
n
gene
nonleth
phenotyp
due
slight
delay
replic
efficaci
wherea
minim
incompat
viral
protein
origin
differ
strain
like
caus
surviv
case
chimer
virus
anim
succumb
diseas
observ
dramat
drop
leukocyt
number
almost
complet
loss
peripher
blood
mononuclear
cell
pbmc
prolifer
activ
upon
phytohemagglutinin
pha
stimul
three
seven
day
inocul
prior
onset
diseas
sign
fig
b
circl
contrast
survivor
experienc
equal
sever
transient
leukocyt
drop
inhibit
lymphocyt
prolifer
less
pronounc
fig
b
triangl
mark
differ
peripher
blood
mononuclear
cell
pbmc
associ
viru
titer
neutral
antibodi
level
cdv
note
two
group
earli
time
point
fig
import
role
cdv
pathogenesi
easi
access
pbmc
ideal
suit
follow
system
cytokin
respons
time
anim
previous
shown
target
primarili
b
cell
lethal
infect
result
rel
reduct
cell
popul
begin
ten
day
post
infect
dpi
von
messl
svitek
cattaneo
assur
compar
sampl
group
determin
infect
level
pbmc
subpopul
composit
differ
time
point
consist
previou
result
observ
infect
cell
relev
chang
pbmc
subpopul
three
dpi
fig
b
compar
dpi
seven
dpi
cell
express
egfp
fig
dpi
could
subdivid
cell
b
cell
monocyt
regardless
diseas
outcom
fig
left
right
panel
onset
clinic
sign
ten
dpi
two
group
diverg
similar
observ
immunolog
paramet
fig
determin
newli
establish
cytokin
assay
allow
discrimin
two
group
earli
diseas
stage
assay
fail
detect
differ
compar
rel
induct
differ
cytokin
mrna
three
seven
dpi
anim
succumb
diseas
survivor
strike
find
gener
lack
cytokin
upregul
anim
infect
lethal
strain
time
point
fig
ac
circl
even
observ
reduct
cytokin
mrna
level
baselin
major
anim
analyz
suggest
infectioninduc
shutdown
gene
express
fig
b
circl
except
upregul
small
subset
anim
examin
fig
middl
panel
circl
contrast
major
anim
infect
nonleth
virus
show
robust
upregul
innat
immun
respons
cytokin
cytokin
three
dpi
sustain
day
seven
fig
b
triangl
earlier
time
point
broad
rang
express
level
observ
subset
anim
display
strong
respons
fig
c
triangl
seven
day
inocul
cytokin
cytokin
also
strongli
express
fig
c
triangl
dramat
drop
leukocyt
number
loss
function
remain
cell
observ
within
first
week
infect
indic
morbillivirus
interfer
induct
appropri
immun
respons
earli
stage
borrow
oldston
schneiderschauli
et
al
better
understand
basi
host
immun
respons
control
ferret
model
establish
semiquantit
realtim
rtpcr
assay
base
ferret
cytokin
sequenc
compar
respons
associ
lethal
diseas
outcom
surviv
found
anim
succumb
diseas
fail
mount
sustain
respons
survivor
show
initi
polar
later
transit
respons
cytokin
respons
cdv
far
mostli
studi
dog
natur
contract
diseas
time
euthanasia
result
repres
thu
profil
late
stage
acut
diseas
phase
onset
neurolog
diseas
recoveri
acut
infect
interestingli
anim
sever
sign
diseas
viremia
time
death
display
low
absent
cytokin
mrna
induct
bloodderiv
rna
consist
initi
find
ferret
studi
grone
frisk
baumgartn
von
messl
svitek
cattaneo
contrast
individu
mild
absent
gener
sign
diseas
neurolog
manifest
mount
broad
respons
blood
also
local
cn
grone
frisk
baumgartn
marku
fail
baumgartn
role
system
local
immun
respons
context
delay
neurolog
form
cdv
remain
investig
ferret
strike
lack
cytokin
respons
anim
infect
lethal
viru
earli
three
dpi
indic
viral
interfer
immun
system
activ
time
infect
pbmc
bare
detect
vitro
demonstr
minut
amount
mv
envelop
suffic
induc
anerg
state
expos
lymphocyt
exact
interact
remain
elucid
schlender
et
al
addit
nonessenti
protein
v
shown
inhibit
activ
antivir
respons
interf
nuclear
local
stat
devaux
et
al
palosaari
et
al
possibl
shut
cytokin
express
observ
lethal
cdv
strain
result
contact
viral
glycoprotein
immun
cell
combin
v
phosphoproteindepend
inhibit
induct
antivir
state
infect
cell
taken
togeth
find
demonstr
diseas
outcom
decid
within
first
day
infect
switch
observ
anim
infect
nonleth
virus
mirror
previou
report
children
natur
infect
mv
express
acut
phase
diseas
increas
coincid
antibodymedi
viru
clearanc
griffin
ward
esolen
moss
et
al
context
elev
level
detect
week
infect
might
import
factor
longlast
immunosuppress
associ
mv
moss
et
al
studi
ferret
infect
nonleth
virus
close
reproduc
find
support
valu
model
character
mechan
underli
morbillivirusinduc
immunosuppress
addit
morbilliviru
pathogenesi
studi
ferret
recogn
model
develop
vaccin
antivir
therapi
influenza
recent
sar
maher
destefano
ter
meulen
et
al
also
use
transmiss
studi
differ
transmiss
spongiform
encephalopathi
bartz
et
al
bartz
et
al
parallel
human
diseas
manifest
sever
bacteri
diseas
includ
helicobacterinduc
gastric
ulcer
hemolyt
urem
syndrom
caus
shiga
toxinproduc
escherichia
coli
campylobacteriosi
orourk
lee
wood
et
al
compar
sampl
anim
differ
diseas
outcom
demonstr
semiquantit
realtim
pcr
assay
suffici
sensit
detect
weak
respons
even
reduct
baselin
level
observ
anim
later
succumb
diseas
time
assay
allow
quantif
respons
across
much
wider
rang
previou
gelbas
approach
von
messl
svitek
cattaneo
enabl
detail
comparison
cytokin
respons
specif
attenu
virus
futur
studi
furthermor
rnabas
assay
easili
appli
variou
tissu
well
bodili
fluid
enabl
assess
local
system
respons
time
thu
add
versatil
new
tool
studi
hostpathogen
interact
model
obtain
sequenc
encod
ferret
well
gapdh
housekeep
gene
total
rna
isol
rneasi
qiagen
pbmc
healthi
anim
stimul
pha
sigma
rna
revers
transcrib
superscript
iii
invitrogen
use
mixtur
oligot
random
hexam
primer
maxim
cdna
output
primer
pair
initi
amplif
ferret
cytokin
base
conserv
region
respect
gene
phylogenet
relat
carnivor
dog
cat
avail
genbank
canin
sequenc
felin
sequenc
partial
ferret
sequenc
determin
von
messl
svitek
cattaneo
ferret
specif
primer
chosen
obtain
increas
part
open
read
frame
either
combin
addit
canin
felinebas
primer
race
accord
manufactur
instruct
generac
racereadi
cdna
kit
invitrogen
primer
pair
realtim
pcr
assay
design
use
primer
quest
program
integr
dna
technolog
tabl
protein
align
calcul
percent
amino
acid
ident
perform
use
megalign
dnastar
lasergen
sampl
analyz
studi
origin
anim
infect
either
one
lethal
strain
von
messl
milosev
cattaneo
rudd
cattaneo
von
messl
nonleth
strain
von
messl
milosev
cattaneo
survivor
infect
chimer
envelop
exchang
virus
caus
lethal
unpublish
result
male
ferret
week
age
marshal
farm
inocul
intranas
tissu
cultur
infecti
dose
respect
viru
blood
sampl
collect
twice
first
two
week
weekli
thereaft
time
point
total
white
blood
cell
count
prolifer
activ
cell
associ
viru
titer
neutral
antibodi
titer
determin
describ
previous
rudd
cattaneo
von
messl
von
messl
et
al
flow
cytometri
analysi
pbmc
subpopul
carri
follow
protocol
publish
previous
von
messl
milosev
cattaneo
von
messl
svitek
cattaneo
cytokin
mrna
quantif
ml
blood
collect
naedtaco
vacuum
tube
vacutain
beckton
dickinson
immedi
three
seven
dpi
pbmc
isol
destroy
erythrocyt
ack
lysi
buffer
mm
nh
cl
mm
khco
mm
edta
ph
resuspend
rnalat
qiagen
store
rna
purifi
use
rneasi
kit
combin
onthecolumn
dnase
treatment
qiagen
yield
quantifi
uv
spectrophotometri
assess
cytokin
express
cdna
produc
ng
rna
combin
primer
dynamo
sybr
green
qrtpcr
reaction
mix
finnzym
reaction
accord
manufactur
instruct
realtim
pcr
perform
rotorgen
use
follow
protocol
denatur
min
follow
cycl
melt
curv
analysi
confirm
reaction
specif
experi
perform
triplic
valu
vari
less
consid
fold
chang
ratio
experiment
control
sampl
gene
calcul
gapdh
level
refer
toward
cycl
gapdh
cross
detect
threshold
ct
substract
ct
valu
gene
interest
time
point
fold
chang
calcul
substract
valu
respect
gene
day
obtain
subsequ
day
transform
valu
absolut
valu
formula
fold
chang
use
schmittgen
et
al
clinic
paramet
anim
infect
lethal
nonleth
cdv
strain
leukocyt
number
b
vitro
prolifer
activ
lymphocyt
c
cellassoci
viru
titer
express
log
tissu
cultur
infecti
dose
tcid
pbmc
neutral
antibodi
titer
first
day
diseas
anim
infect
lethal
strain
repres
circl
infect
nonleth
viru
survivor
infect
chimer
envelop
exchang
virus
triangl
day
postinfect
indic
x
axi
leukocyt
number
prolifer
activ
cellassoci
viru
titer
neutral
antibodi
titer
axi
error
bar
repres
standard
deviat
narrow
dot
line
indic
cutoff
valu
associ
moder
upper
line
sever
lower
line
immunosuppress
wider
dot
line
repres
protect
threshold
neutral
antibodi
comparison
cytokin
respons
anim
infect
lethal
nonleth
cdv
strain
innat
immun
b
c
cytokin
mrna
express
group
three
seven
day
post
infect
anim
infect
lethal
strain
repres
circl
infect
nonleth
virus
survivor
triangl
fold
mrna
express
chang
compar
preinfect
level
anim
indic
axi
sampl
analyz
triplic
sampl
variat
among
triplic
less
includ
analysi
result
variabl
number
individu
plot
differ
cytokin
black
bar
repres
mean
sampl
hatch
zone
repres
threshold
level
fold
express
chang
consid
normal
variabl
primer
pair
use
cytokin
realtim
pcr
assay
